Dr Reddys Laboratories (RDY) EPS (Basic) (2009 - 2026)
Dr Reddys Laboratories (RDY) posted EPS (Basic) of $0.06 for Q2 2026, up 1071.15% on a QoQ basis from $0.0 in Q1 2026, and down 71.71% year-over-year from $0.2 in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) EPS (Basic) (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported EPS (Basic) for 18 years, with the latest figure at $0.06 in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 71.71% year-over-year to $0.06 in Q2 2026; TTM through Jun 2026 was $0.02, a 96.97% decrease from a year earlier, with the FY2026 full-year figure at $0.58, down 30.7% from the prior year.
- EPS (Basic) was $0.06 for Q2 2026 at Dr Reddys Laboratories, up from $0.0 in the prior quarter.
- The five-year high for EPS (Basic) was $0.22 in Q3 2023, with the low at -$0.24 in Q4 2025.
- Average EPS (Basic) over 5 years is $0.13, with a median of $0.19 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) surged 1350.97% in 2023, then plunged 221.13% in 2025.
- Over 5 years, EPS (Basic) stood at $0.14 in 2022, then soared by 41.41% to $0.2 in 2023, then grew by 0.86% to $0.2 in 2024, then slumped by 221.13% to -$0.24 in 2025, then soared by 123.09% to $0.06 in 2026.
- The last three EPS (Basic) figures came in at $0.06 (Q2 2026), $0.0 (Q1 2026), and -$0.24 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn | -0.49 |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -0.10 |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn | 0.06 |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 0.22 |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn | 0.69 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -0.23 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn | 1.17 |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn | 0.70 |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn | 0.06 |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.06 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | 0.20 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.20 |
| Sep 30, 2023 | 0.22 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.20 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.11 |